CD47 and neoplasm: A recent experimental study by Hutter and co-workers has indicated that tumour-associated microglia are capable of tumour cell phagocytosis in vivo if the immune evasion of tumour cells is blocked by a humanized anti-CD47 monoclonal antibody [29].